BVI Announces Certification for its Intraocular Lens Portfolio under the European Medical Device Regulation

Posted on

WALTHAM, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) -- BVI, a diversified global ophthalmic device company, today announced certification for its intraocular lens (IOL) portfolio under the European Medical Device Regulation (MDR, (EU) 2017/745) from its Notified Body, the British Standards Institution (BSI)¹. The new regulatory criteria came into effect in May 2021, replacing the prior Medical Device Directive (MDD). Read More

BVI acquires Benz Research & Development, strengthening end to end IOL design, production and sales capabilities

Posted on
  • Benz R&D is the leading technologically advanced independent supplier of performance materials and manufacturing technology to the IOL industry
  • BVI’s vertical integration will accelerate manufacturing capacity and geographic sales expansion, and the IOL material capabilities of BVI’s world leading PhysIOL® lens platform

Waltham, MA – October 15, 2020  Read More

Gold | Professional Sales Tool, 2020

Posted on

BVI and Merge 

CustomEyes Configurator

With 1,400 products sold in markets around the world, BVI was struggling with a convoluted sales process. Sales reps were frustrated with antiquated procedures, including a physical catalog to find and enter SKUs into a spreadsheet, emailing orders to support teams for verification and building the sample pack.  Continue reading the article today! Read More

BVI expands Malosa single-use instrument range in the US

Posted on
  •  BVI broadens its widely popular range of Malosa® single-use ophthalmic instruments to
    span cataract, oculoplastic, corneal refractive procedures and other office-based
    procedures.
  • Malosa single-use instruments help surgeons focus on precision, reduce cross
    contaminations, and increase operating room efficiency.

Waltham, MA – September 8, 2020 – BVI, the fastest growing diversified company in
ophthalmology, today announced the extension of its Malosa®
range of single-use ophthalmic
instruments in the US. The US Malosa portfolio will now include specialty instruments for use in
corneal refractive surgery, complementing the existing single-use product range for cataract,
oculoplastic and office-based procedures, such as LASIK, PRK and SMILE®. Read More